As the tenth most common cancer in the world, scientists are working hard to deliver treatments to alleviate the impact of bladder cancer on patients
The current standard of treatment for these patients includes a high-burden version of chemotherapy, followed by radical cystectomy. On top of that, the bladder permeability barrier often makes it difficult for medications to make their way to the tumor. This podcast — provided by Janssen — explains how innovative technologies within the field are changing that.
Check out the podcast episodes below.
⬆Ep. 2
A Clinician’s Journey Pt. II
In Episode 2 of Breaking Down Barriers, we take a look at the recent research breakthroughs happening at Janssen Oncology. Hear Dr. Christopher Cutie, bladder cancer researcher and the disease area leader of bladder cancer at Janssen, discuss these breakthroughs and how they have the potential to transform bladder cancer treatment and improve the lives of patients.
Ep. 1
A Clinician’s Journey Pt. I
In this inaugural episode of Breaking Down Barriers, Dr. Christopher Cutie opens up about his personal experience working with bladder cancer patients and the motivation behind dedicating his life to improving bladder cancer treatments.
– BioPharma Dive's studioID
